EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Real-World Effectiveness and Safety of Allergen Immunotherapy with a Combination of Glutaraldehyde-Polymerized Allergen Extracts of Dermatophagoides spp. and Lepidoglyphus destructor in Adults and Children

Francisco Javier Carballada González, Fernando García González, Belén Hinojosa Jara, Fernando Rodríguez Fernández, Miguel Añó García, Antonio Maraví San Martín, Luis Alfredo González Guzmán iD, Irene García Gutiérrez iD, Sofía Alonso Juaristi, María Jesús Giménez Revilla, Miguel Casanovas iD, Judith Díaz-García iD und 1 weitere

International Journal of Molecular Sciences · 19.08.2026 · 27 (16) · 7397

DOI: 10.3390/ijms27167397 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.08.2026. Verfasst von Francisco Javier Carballada González und 12 weiteren Autor:innen. Beteiligte Einrichtung: Lucus Augusti University Hospital, 27003 Lugo, Spain. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Antigens, Dermatophagoides, Asthma, Allergens. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inmunotek (Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mite-induced allergic respiratory diseases are a major global health concern, and evidence on allergen immunotherapy (AIT) combining allergens from different mite families remains limited, particularly for Lepidoglyphus destructor. This study evaluated the effectiveness and safety of subcutaneous allergen immunotherapy containing glutaraldehydempolymerized extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae, and L. destructor in mite-allergic patients in Spain. This retrospective multicenter study included 199 patients with allergic rhinoconjunctivitis, with or without asthma. Effectiveness outcomes included combined symptom and medication scores (CSMS), symptom scores, and medication use. Safety outcomes included adverse reactions. Mixed models for repeated measures showed significant improvements in rhinoconjunctivitis and asthma outcomes (all p < 0.001). Adjusted LS-mean rhinoconjunctivitis CSMS decreased by 50.7% at T1 and 76.1% at T4; symptom and medication scores decreased by 85.3% and 69.3%, respectively, at T4. Asthma CSMS decreased by 43.1% at T1 and 89.0% at T5, while symptom and medication scores decreased by 93.4% and 88.5%, respectively. Similar patterns were observed in children. No systemic reactions occurred. Twenty mild local reactions were recorded in 17 patients (8.5%), corresponding to an estimated rate of 0.32% across 6169 injections. This AIT was associated with sustained clinical improvement and a favorable safety profile in adults and children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicAntigens, DermatophagoidesAsthmaAllergensGlutaralMitesConjunctivitis, AllergicHumansAnimalsFemaleMaleAdultChildRetrospective StudiesAdolescentMiddle AgedTreatment OutcomeDust Mite AllergyYoung Adult

Stichwörter der Autor:innen

DermatophagoidesLepidoglyphus destructorallergen immunotherapyreal-world evidence

Substanzen

Antigens, DermatophagoidesAllergensGlutaral

Autor:innen und Institutionen

  • Lucus Augusti University Hospital, 27003 Lugo, Spain.
  • University Hospital Basurto, 48013 Bilbao, Spain.
  • Belén Hinojosa Medical Clinic, 21001 Huelva, Spain.
  • University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
  • Alergocantabria, 39002 Santander, Spain.
  • Centro Médico Sanitas Sevilla, 41010 Sevilla, Spain.

ORCID-Profile: Luis Alfredo González Guzmán, Irene García Gutiérrez, Miguel Casanovas, Judith Díaz-García

Förderung

  • Inmunotek (Spain)

Zitieren

APA

Carballada González, F. J., García González, F., Hinojosa Jara, B., Rodríguez Fernández, F., Añó García, M., Maraví San Martín, A., González Guzmán, L. A., García Gutiérrez, I., Alonso Juaristi, S., Giménez Revilla, M. J., Casanovas, M., Díaz-García, J., & Ruiz García, Y. (2026). Real-World Effectiveness and Safety of Allergen Immunotherapy with a Combination of Glutaraldehyde-Polymerized Allergen Extracts of Dermatophagoides spp. and Lepidoglyphus destructor in Adults and Children. International Journal of Molecular Sciences, 27(16), 7397. https://doi.org/10.3390/ijms27167397

Vancouver

Carballada González FJ, García González F, Hinojosa Jara B, Rodríguez Fernández F, Añó García M, Maraví San Martín A, et al. Real-World Effectiveness and Safety of Allergen Immunotherapy with a Combination of Glutaraldehyde-Polymerized Allergen Extracts of Dermatophagoides spp. and Lepidoglyphus destructor in Adults and Children. International Journal of Molecular Sciences. 2026;27(16):7397. doi:10.3390/ijms27167397

BibTeX
@article{CarballadaGonzlez2026,
  author = {Carballada González, Francisco Javier and García González, Fernando and Hinojosa Jara, Belén and Rodríguez Fernández, Fernando and Añó García, Miguel and Maraví San Martín, Antonio and González Guzmán, Luis Alfredo and García Gutiérrez, Irene and Alonso Juaristi, Sofía and Giménez Revilla, María Jesús and Casanovas, Miguel and Díaz-García, Judith and Ruiz García, Yara},
  title = {Real-World Effectiveness and Safety of Allergen Immunotherapy with a Combination of Glutaraldehyde-Polymerized Allergen Extracts of Dermatophagoides spp. and Lepidoglyphus destructor in Adults and Children},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7397},
  doi = {10.3390/ijms27167397}
}
Kostenlos starten →